ARTICLE | Clinical News
Multipotent bone marrow-derived stem cells regulatory update
January 16, 2012 8:00 AM UTC
FDA granted Fast Track designation for AlloCure's AC607 to treat acute kidney injury (AKI). The company plans to start Phase II testing of the formulation of allogeneic bone marrow-derived mesenechyma...